Immuneering director granted 33,350 stock options
Immuneering Corp director Thomas J. Schall received a grant of stock options covering 33,350 shares of Class A common stock at an exercise price of $4.12 per share.
Rhea-AI Filing Summary
Immuneering Corp director Thomas J. Schall received a grant of stock options covering 33,350 shares of Class A common stock at an exercise price of $4.12 per share. The options vest in equal monthly installments over one year starting on July 11, 2026.
The award will be fully vested by June 11, 2027 or on the date of the 2027 annual meeting of stockholders, whichever occurs first. This is a compensation-related equity grant rather than an open-market stock purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 33,350 shares
Grant/Award
1 txn
Insider
Schall Thomas J.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 33,350 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 33,350 contracts (Direct)
Footnotes (1)
- F1. The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 11, 2026, and will be fully vested and exercisable on June 11, 2027, or the date of the 2027 annual meeting of stockholders, whichever comes first.
Key Figures
Stock options granted: 33,350 options
Exercise price: $4.12 per share
Underlying shares: 33,350 shares
+3 more
6 metrics
Stock options granted
33,350 options
Grant to director Thomas J. Schall
Exercise price
$4.12 per share
Stock option strike price
Underlying shares
33,350 shares
Class A common stock underlying the options
Expiration date
June 11, 2036
Option expiration if unexercised
Vesting start
July 11, 2026
Monthly vesting commencement date
Full vest date
June 11, 2027
Or 2027 annual meeting date, whichever first
Key Terms
Stock Option, Class A Common Stock, exercise price, vesting, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Class A Common Stock financial
"underlying_security_title: "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
exercise price financial
"conversion_or_exercise_price: "4.1200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests and becomes exercisable in equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of stockholders financial
"or the date of the 2027 annual meeting of stockholders, whichever comes first"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Immuneering Corp (IMRX) report for Thomas J. Schall?
Immuneering Corp reported a stock option grant to director Thomas J. Schall. He received options for 33,350 shares of Class A common stock as a compensation award, not through an open-market purchase or sale, according to the Form 4 filing details.
How many Immuneering (IMRX) stock options were granted to Thomas J. Schall and at what price?
Thomas J. Schall was granted 33,350 stock options at an exercise price of $4.12 per share. These options relate to Class A common stock and were issued as a grant/award acquisition, with no cash paid at the time of the grant.
When do Thomas J. Schall’s Immuneering (IMRX) stock options vest?
The stock options vest in equal monthly installments over one year. Vesting starts on July 11, 2026, and the options will be fully vested by June 11, 2027, or on the date of the 2027 annual meeting of stockholders, whichever comes first.
Is the Immuneering (IMRX) Form 4 transaction a stock sale or purchase?
The Form 4 shows a compensation grant, not a market trade. The transaction is coded as a grant or award acquisition of stock options, meaning no open-market buying or selling of Immuneering shares occurred in this filing.
What type of security did Immuneering (IMRX) grant to Thomas J. Schall?
Immuneering granted a stock option linked to Class A common stock. The option covers 33,350 underlying shares and carries an exercise price of $4.12 per share, expiring on June 11, 2036, if not exercised earlier after vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
